PT878195E - Utilizacao de um composto 2-aroil-3-arilbenzo(b)tiofeno para a reducao de fibrinogenio - Google Patents

Utilizacao de um composto 2-aroil-3-arilbenzo(b)tiofeno para a reducao de fibrinogenio

Info

Publication number
PT878195E
PT878195E PT98303055T PT98303055T PT878195E PT 878195 E PT878195 E PT 878195E PT 98303055 T PT98303055 T PT 98303055T PT 98303055 T PT98303055 T PT 98303055T PT 878195 E PT878195 E PT 878195E
Authority
PT
Portugal
Prior art keywords
aroyl
compound
thyrofen
arybenzo
reducing fibrinogen
Prior art date
Application number
PT98303055T
Other languages
English (en)
Inventor
Pamela Wang Anderson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT878195E publication Critical patent/PT878195E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT98303055T 1997-04-22 1998-04-21 Utilizacao de um composto 2-aroil-3-arilbenzo(b)tiofeno para a reducao de fibrinogenio PT878195E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4459197P 1997-04-22 1997-04-22

Publications (1)

Publication Number Publication Date
PT878195E true PT878195E (pt) 2002-09-30

Family

ID=21933208

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98303055T PT878195E (pt) 1997-04-22 1998-04-21 Utilizacao de um composto 2-aroil-3-arilbenzo(b)tiofeno para a reducao de fibrinogenio

Country Status (23)

Country Link
US (1) US6025373A (pt)
EP (1) EP0878195B1 (pt)
JP (1) JP2001524101A (pt)
KR (1) KR20010012084A (pt)
CN (1) CN1254255A (pt)
AT (1) ATE219364T1 (pt)
AU (1) AU741720B2 (pt)
BR (1) BR9809286A (pt)
CA (1) CA2287196A1 (pt)
DE (1) DE69806098T2 (pt)
DK (1) DK0878195T3 (pt)
EA (1) EA002237B1 (pt)
ES (1) ES2178111T3 (pt)
HU (1) HUP0002727A3 (pt)
ID (1) ID22910A (pt)
IL (1) IL132504A0 (pt)
NO (1) NO995132L (pt)
NZ (1) NZ500389A (pt)
PL (1) PL336638A1 (pt)
PT (1) PT878195E (pt)
TR (1) TR199902605T2 (pt)
WO (1) WO1998047365A1 (pt)
ZA (1) ZA983298B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103740A (en) * 1997-08-21 2000-08-15 Eli Lilly And Company Methods for lowering platelet counts
FR2777784B1 (fr) * 1998-04-27 2004-03-19 Arepa Composition pharmaceutique a base d'estrogene et de progesterone
US6353003B1 (en) 1998-06-17 2002-03-05 Eli Lilly And Company Method for reducing levels of homocysteine and C-reactive protein

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
WO1993011704A1 (en) * 1991-12-17 1993-06-24 Eduard Emmanuilovich Godik Method and device for diagnosis of living organism
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US5445941A (en) * 1993-06-21 1995-08-29 Eli Lilly And Company Method for screening anti-osteoporosis agents
KR950010891A (ko) * 1993-10-15 1995-05-15 피터 지. 스트링거 내성 종양을 치료하는 방법
US5441965A (en) * 1993-12-21 1995-08-15 Eli Lilly And Company Methods of inhibiting thrombin
US5476862A (en) * 1993-12-21 1995-12-19 Eli Lilly And Company Methods of increasing thrombomodulin expression
CZ246597A3 (cs) * 1995-02-06 1998-06-17 Eli Lilly And Company Použití sloučeniny k přípravě terapeutického přípravku pro inhibici účinku interleukinu 6, účinků faktoru inhibice leukemie a inhibici systému povrchového receptoru
US5731328A (en) * 1995-10-10 1998-03-24 Eli Lilly And Company Methods of inhibiting plasminogen activator inhibitor 1

Also Published As

Publication number Publication date
US6025373A (en) 2000-02-15
NO995132D0 (no) 1999-10-21
ES2178111T3 (es) 2002-12-16
CA2287196A1 (en) 1998-10-29
JP2001524101A (ja) 2001-11-27
DK0878195T3 (da) 2002-07-15
IL132504A0 (en) 2001-03-19
KR20010012084A (ko) 2001-02-15
TR199902605T2 (xx) 2000-02-21
WO1998047365A1 (en) 1998-10-29
NZ500389A (en) 2001-07-27
CN1254255A (zh) 2000-05-24
DE69806098T2 (de) 2003-01-02
EP0878195B1 (en) 2002-06-19
MX9909548A (es) 2003-02-27
AU7250398A (en) 1998-11-13
DE69806098D1 (de) 2002-07-25
EP0878195A1 (en) 1998-11-18
ZA983298B (en) 1999-10-20
HUP0002727A2 (hu) 2001-08-28
PL336638A1 (en) 2000-07-03
EA199900959A1 (ru) 2000-06-26
ATE219364T1 (de) 2002-07-15
HUP0002727A3 (en) 2001-09-28
NO995132L (no) 1999-10-21
EA002237B1 (ru) 2002-02-28
BR9809286A (pt) 2000-07-04
ID22910A (id) 1999-12-16
AU741720B2 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
PT1109812E (pt) Pirrolobenzodiazepinas
DE60143984D1 (de) Neue phenylalanin-derivate
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
HN1998000036A (es) Compuesto de pirazina
BR9811948A (pt) Secretores de hormÈnio do crescimento
IT1285770B1 (it) Composti corticoidei
DE69005686D1 (de) Dentalklebstoffmischung.
ES2145818T3 (es) Utilizacion de la (s)-(-)-alfa-etil-2-oxo-1-pirrolidin-acetamida para la preparacion de medicamentos destinados al tratamiento de la ansiedad.
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
DE69828043D1 (de) Fluoridfreie zahnremineralisierung
SE9801494D0 (sv) Novel use
DK0417003T3 (da) Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation
FI892222A (fi) Peptidalkoholer med antikoagulantverkan.
DE69003776D1 (de) Dentalklebstoffmischung.
DK0750616T3 (da) Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
ES2085898T3 (es) Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina.
ES2140672T3 (es) Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.
PT878195E (pt) Utilizacao de um composto 2-aroil-3-arilbenzo(b)tiofeno para a reducao de fibrinogenio
DK0617959T3 (da) Lægemiddel til behandling af hudsygdomme
DK0520372T3 (da) Inositol-phosphat-analoger som calciumantagonistiske stoffer
ATE176477T1 (de) Neue phospholipidderivate
FI880868A (fi) Välituotteina käyttökelpoisia tetratsoliyhdisteitä
DE59808166D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure als mukolytikum
BR9304388A (pt) Composição terapêutica de uso nasal
LT2332B (lt) Nitronaftalino monopakeisti sulfamidai kaip pusiauproduktai nesimetriniu 5-aminonaftalin-1-sulfamidudariniu gavimui